Panluminate Inc.

Panluminate Inc. is a woman-owned small business headquartered in New Haven, Connecticut, specializing in advanced microscopy and spatial biology technologies. The company focuses on developing innovative imaging solutions that enable high-resolution, three-dimensional mapping of molecular structures within biological tissues. Registered in SAM.gov with a current registration valid through April 2026, Panluminate Inc. provides cutting-edge research and development services primarily in the biomedical and life sciences sectors, with a particular emphasis on developing novel microscopy and proteomics technologies.

The company has secured multiple federal grants from prestigious institutes such as the National Institute on Aging, National Eye Institute, National Institute of General Medical Sciences, National Heart, Lung, and Blood Institute, and the National Human Genome Research Institute. These grants, totaling approximately $3.1 million, support the development of advanced imaging technologies like Pan-Expansion Microscopy (PAN-EXM), FLASH-PULSE, Pan-Optix, CHROMEX30, and AFLEX. These technologies aim to revolutionize spatial proteomics by enabling researchers to map protein distribution and tissue ultrastructure at nanoscale resolution using all-optical methods. Specific project goals include developing automated microfluidics systems, creating novel probes for high-signal imaging, and validating these technologies across various tissue types including brain, kidney, lung, and retinal tissues. The projects consistently focus on creating more efficient, cost-effective, and high-resolution imaging solutions that can be widely disseminated to research and biotech laboratories.